Skip to main content

2022 Worldwide Oligonucleotide Synthesis Industry Insights - RNA Based Vaccines Are Driving Growth

DUBLIN, Jan. 28, 2022 /PRNewswire/ -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized Forecasting and Analysis" report has been added to...
  • Author:
  • Publish date:

DUBLIN, Jan. 28, 2022 /PRNewswire/ -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized Forecasting and Analysis" report has been added to's offering.

Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and, even, Data Storage! The market for small snippets of DNA, called Oligonucleotides, is growing into a market for Synthetic DNA where organisms, like algae, are "custom designed" to produce food and medicine while consuming few resources.In applications like CRSPR Gene Editing and COVID-19 Synthetic Antibodies these "Oligos" are already going to work. The possibilities, and market growth are unlimited. Our analysis shows that investors do not yet understand the scope of this technology and the enormous market opportunity. Small biotechs are in a position to become huge multinationals, all based on producing DNA and its building blocks. Learn all about it and see the publisher's forecasts in this comprehensive report.This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving fast. It is coming out of the lab and onto the desktop as genetics crosses the chasm into mainstream commerce.The report includes five year market forecasts. Key Topics Covered:

1. Market Guides1.1 Situation Analysis1.2 Guide for Executives and Marketing Staff1.3 Guide for Investment Analysts and Management Consultants 2. Introduction and Market Definition2.1 What is Oligonucleotide Synthesis?2.1.1 The Enzyme Race2.1.2 Data Storage - The Elephant in the Room2.2 Market Definition2.2.1 Market Size2.2.2 Currency2.2.3 Years2.3 Methodology2.3.1 Authors2.3.2 Sources2.4 U.S. Medical Market and Pharmaceutical Research Spending - Perspective2.4.1 U.S. Expenditures for Pharmaceutical Research2.5 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic2.5.1 Global Healthcare Spending2.5.2 Spending on Diagnostics2.5 Important Role of Insurance for Diagnostics

3. Oligonucleotide Synthesis3.1 Synthesis Technology3.2 Automation3.3 Types of Oligonucleotides3.4 PCR Primers3.5 PCR Assays and Panels3.6 Sequencing3.7 DNA Microarrays3.8 Fluorescence In Situ Hybridization (FISH)3.9 Antisense Oligonucleotides3.10 Other Uses of Oligonucleotides3.11 Relationship to CRISPR and Gene Editing 4. Industry Overview4.1 Players in a Dynamic Market4.1.1 Academic Research Lab4.1.2 Genome and Bio Foundries4.1.3 Chemical and Food Product Supplier4.1.4 Synthetic Gene and Oligo Supplier4.1.5 Diagnostic Manufacturer4.1.6 Pharmaceutical Company4.1.7 Audit Body 5. Market Factors5.1 Factors Driving Growth5.1.1 The Role of Diagnostics and the Covid Effect5.1.2 The RNA Based Vaccine5.1.3 Genomic Blizzard5.1.4 Antisense Revival5.1.5 New Applications5.2 Factors Limiting Growth5.2.1 Declining Price5.2.2 Technology Lag5.2.3 COVID Realignment5.3 The Next Five Years 6. Oligonucleotide Synthesis Recent Developments6.1 Recent Developments - Importance and How to Use This Section6.1 Importance of These Developments6.1.2 How to Use This Section6.2 New Rapid Multiplexed PCR Assay Uses Oligo Probes6.3 MIT Devises Oligo 'File System' for DNA Data Storage6.4 Nuclera Acquires E Ink Digital Microfluidics Business6.5 Twist Bioscience Hits Milestone for DNA Data Storage6.6 Twist Bioscience, Vivlion Partner on RNA Libraries for CRISPR6.7 DNA Script Launching Benchtop Synthesizer for 'DNA on Demand'6.8 RNA Disease Dx to Develop PoC Covid Test6.9 Evonetix and Analog Devices Develop GEN3 DNA Synthesis Platform6.10 ATDBio Receives Grant for Cancer Diagnosis Project6.11 Twist Bioscience Announces SARS-CoV-2 Therapeutic Ab6.12 Drugmakers boost oligo capacity amid Covid-196.13 Aligos Therapeutics in Study of Oligo Candidate6.14 DNA Script Raises $89M for SYNTAX Launch6.15 Codexis & Molecular Assemblies Partner for DNA Synthesis6.16 NuProbe Licenses Oligo Technology from Rice6.17 Genome editing with Cas9-oligo conjugates6.18 OliX Pharma and AM Chemicals Partner for RNA Synthesis Support6.19 Twist Bio To Pay $22.5M To End Trade Secrets Suit6.20 DNA Script, partners get grant for data storage6.21 Xi's STA unit opens oligonucleotide plant6.22 Agilent Doubles Capacity to Produce Oligos6.23 GeneDesign Opens Oligo Development Center 7. Profiles of Key Companies7.1 Abbott Diagnostics7.2 Ajinomoto Bio-Pharma7.3 Alnylam Pharmaceuticals7.4 Amyris7.5 Ansa BioTechnologies7.6 ATDBio7.7 ATG biosynthetics7.8 ATUM7.9 Bayer7.10 Beckman Coulter Diagnostics7.11 Becton, Dickinson and Company7.12 Biomatik7.13 bioMerieux Diagnostics7.14 Bio-Rad Laboratories, Inc.7.15 Bio-Synthesis7.16 Blue Heron Biotechnology (Eurofins Genomic)7.17 Camena Bioscience7.18 Cepheid (Danaher)7.19 Codexis7.20 Diasorin S.p.A.7.21 DNA Script7.22 Enzo Life Sciences, Inc.7.23 Eurofins Scientific7.24 Eurogentec (Kaneka)7.25 Evonetix7.26 GE Healthcare7.27 Genomatica7.28 Genscript Biotech7.29 Hologic7.30 Integrated DNA Technologies(Danaher)7.31 Ionis Pharmaceuticals7.32 Janssen Diagnostics7.33 Kern Systems7.34 LGC Biosearch Technologies7.35 Maravai LifeSciences Holdings7.36 Merck & Co., Inc7.37 Microsynth7.38 Millipore Sigma7.39 Molecular Assemblies7.40 Nitto Denko(Avecia)7.41 Nuclera7.42 Perkin Elmer7.43 Primerdesign(Novacyt)7.44 Qiagen Gmbh7.45 Roche Molecular Diagnostics7.46 Seegene7.47 Siemens Healthineers7.48 Synthego7.49 Thermo Fisher Scientific Inc7.50 Twist Bioscience 8. Oligonucleotide Synthesis Global Market Overview 9. Global Market by Length9.1 <_0 mer="mer" />9.1.1 Table - <_0 mer="mer" market="market" by="by" />9.1.2 Chart - <_0 mer="mer" market="market" segment="segment" />9.2 21-50 mer Market9.2.1 Table - 21-50 mer Market by Country9.2.2 Chart - 21-50 mer Market Segment Growth9.3 51-100 mer Market9.3.1 Table - 51-100 mer Market by Country9.3.2 Chart - 51-100 mer Market Segment Growth9.4 >100 mer Market9.4.1 Table - >100 mer Market by Country9.4.2 Chart - >100 mer Market Segment Growth 10. Global Market by Application10.1 Research Market10.1.1 Table - Research Market by Country10.1.2 Chart - Research Market Segment Growth10.2 Diagnostics Market10.2.1 Table - Diagnostics Market by Country10.2.2 Chart - Diagnostics Market Segment Growth10.3 Therapeutics Market10.3.1 Table - Therapeutics Market by Country10.3.2 Chart - Therapeutics Market Segment Growth10.4 Data Market10.4.1 Table - Data Market by Country10.4.2 Chart - Data Market Segment Growth

11. Global Market by Product11.1 Oligonucleotides Market11.1.1 Table - Oligonucleotides Market by Country11.1.2 Chart - Oligonucleotides Market Segment Growth11.2 Instruments Market11.2.1 Table - Instruments Market by Country11.2.2 Chart - Instruments Market Segment Growth11.3 Reagents Market11.3.1 Table - Reagents Market by Country11.3.2 Chart - Reagents Market Segment Growth 12. AppendicesFor more information about this report visit

Media Contact:

Research and Markets Laura Wood, Senior Manager    For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets